Quantcast

Latest Neurogenesis Stories

2011-04-20 12:05:00

ROCKVILLE, Md., April 20, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced it has signed a Memorandum of Understanding with BaYi Brain Hospital in Beijing, China. Under the agreement, BaYi Brain and Neuralstem will jointly prepare a clinical protocol for treatment of motor deficits due to ischemic stroke. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) BaYi Brain will prepare the Mandarin version of the clinical trial documents and submit the documents to...

441abb83702ba0c7ba248269218d51041
2011-04-12 11:10:00

British scientists using human stem cells claim to have discovered how antidepressants create new brain cells, helping drug researchers develop more efficient medicines to fight depression, Reuters reports. Depression affects an estimated 121 million people worldwide, according to the World Health Organization (WHO) and is a primary cause of disability worldwide. It is estimated that less than 25 percent of sufferers have access to effective treatments. Antidepressants such as tricyclics and...

2011-03-25 12:03:15

A group of scientists at Marshall University is conducting research that may someday lead to new treatments for repair of the central nervous system. Dr. Elmer M. Price, who heads the research team and is chairman of Marshall's Department of Biological Sciences, said his group has identified and analyzed unique adult animal stem cells that can turn into neurons. Price said the neurons they found appear to have many of the qualities desired for cells being used in development of therapies for...

2011-03-10 15:40:00

Two studies published by an interdisciplinary team of Hong Kong researchers in the current special issue of Cell Transplantation (20:1), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/ , link the regrowth of key adult brain cells (neurogenesis) in two critical areas of the brain to both the benefits of exercise as a stress reducer and also to sexual behavior and reproductive issues. The two studies reviewing the causes and impacts of neurogenesis came out of a...

2011-03-08 07:46:31

(Ivanhoe Newswire) -- Northwestern Medicine researchers for the first time have transformed a human embryonic stem cell into a critical type of neuron that dies early in Alzheimer's disease and is a major cause of memory loss. This new ability to reprogram stem cells and grow a limitless supply of the human neurons will allow a wave of drug testing for Alzheimer's disease, allow researchers to study why neurons die, and could potentially lead to transplanting the new neurons into people with...

2011-03-01 06:00:00

ROCKVILLE, Md., March 1, 2011 /PRNewswire/ -- Neuralstem, Inc. (Amex: CUR) announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single...

2011-02-09 11:56:00

ROCKVILLE, Md., Feb. 9, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients. (Logo:...

2011-01-28 06:00:00

ROCKVILLE, Md., Jan. 28, 2011 /PRNewswire/ -- Neuralstem, Inc. (Amex: CUR) announced that it has reach a settlement with ReNeuron, Ltd. ending litigation between the parties. The confidential settlement agreement resolves all claims asserted by Neuralstem against ReNeuron in Neuralstem, Inc. v. ReNeuron, Ltd., Case No. CV 08-02168 R (AGRx), which was pending in the United States District Court for the Central District of California. Although the contents of the agreement have not been...

2011-01-06 16:53:44

Findings may have implications for repairing brain injury, studying diseases such as autism and brain cancer For years, the majority of research on reactive oxygen species (ROS) "“ ions or very small molecules that include free radicals "“ has focused on how they damage cell structure and their potential link to stroke, cardiovascular disease and other illnesses. However, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have shown for...

2010-12-16 07:10:00

ROCKVILLE, Md., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related